Name: Teva, Cephalon Gets $72 Million EU Fine for Pay-for-Delay (1)
Brand: bloomberglaw.com
SKU: bloomberglaw-com-30
Availability: OnlineOnly

critic

Teva, Cephalon Gets $72 Million EU Fine for Pay-for-Delay (1)

preview

Free Newsletter Sign Up Login Log in to access all of your BLAW products Single Sign-On Free Newsletter Sign Up Teva Pharmaceutical Industries Ltd. and its Cephalon unit were fined 60.5 million euros ($72 million) by the European Union for a pact that delayed sales of a cheaper version of a sleep-disorder drug.Teva received cash payments and struck beneficial commercial side deals with Cephalon that stopped it rolling out a generic version of Cephalon’s modafinil medicine, the European Commission said Thursday in an emailed statement. Their pay-for-delay pact lasted from 2005 until 2011, when Teva bought Cephalon for $6.2 billion.The fine ends a nine-year probe and concludes a long antitrust crusade against so-called pay-for-delay deals between companies that ... Aoife White Bloomberg News © 2022 The Bureau of National Affairs, Inc. All Rights Reserved

Free Newsletter Sign Up Login Log in to access all of your BLAW products Single Sign-On Free Newsletter Sign Up Teva Pharmaceutical Industries Ltd. and its Cephalon unit were fined 60.5 million euros ($72 million) by the European Union for a pact that delayed sales of a cheaper version of a sleep-disorder drug.Teva received cash payments and struck beneficial commercial side deals with Cephalon that stopped it rolling out a generic version of Cephalon’s modafinil medicine, the European Commission said Thursday in an emailed statement. Their pay-for-delay pact lasted from 2005 until 2011,...

public

Aoife White

bloomberglaw.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Teva, Cephalon Gets $72 Million EU Fine for Pay-for-Delay (1)

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS